About BugSpeaks
BugSpeaks is a Healthcare company based in Bengaluru (India) founded in 2014 by Kumar Sankaran, Prabhath Kamati Manjappa, and Debojyoti Dhar. It offers gut microbiome analysis and personalized dietary advice for health improvement. It operates on a D2C and B2B model. The company has 17 employees. Its chief executive, as recorded, is Kumar Sankaran. Its website bugspeaks.com draws about 30 thousand monthly visits. Its Indian entity Leucine Rich Bio Private Limited reported revenue of ₹1.62 Cr. BugSpeaks offers products and services including BugSpeaks Test and Probiotics and Synbiotics. Its focus areas include Biotech, Microbiome Analysis, Gut Health Diagnostics and Nutraceuticals.
Company details
Leucine Rich Bio , Based In Bangalore, India, Focuses On Gut Microbiome Testing Through The Bugspeaks Platform. They Collect And Analyze Stool Samples To Deliver Reports With Tailored Recommendations For Prebiotics, Probiotics, And Food To Enhance Immunity, Digestion, And Manage Conditions Like Diabetes. The Company Serves Individuals And Partners With Clinics, Emphasizing Transparency And Accuracy In Health Insights.
- Headquarters Bengaluru, India
- Employees 17
- Founders Kumar Sankaran, Prabhath Kamati Manjappa, Debojyoti Dhar
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bugspeaks.com
- Social LinkedIn X Facebook Instagram
- Legal Name Leucine Rich Bio Private Limited
- Date of Incorporation 21 Aug, 2014
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1.62 Cr
FY 2024 · +57% YoY
- Net Loss-₹54 Lakh
FY 2024 · -33% margin
- EBITDA-₹34.6 Lakh
FY 2024 · -21% margin
- Employee Count17
Associated legal entities of BugSpeaks
BugSpeaks operates through Leucine Rich Bio Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Leucine Rich Bio Private Limited CIN U72200KA2014PTC075922 | Active | 21 Aug 2014 | Bangalore, Karnataka | ₹1.6 Cr | 17 | 4 | View details |
Products & Services of BugSpeaks
BugSpeaks offers a comprehensive portfolio of products and services, including BugSpeaks Test and Probiotics and Synbiotics.
Analyzes gut microbiome for personalized health and dietary recommendations.
Formulated supplements based on microbiome data for gut health improvement.
Board of directors of Leucine Rich Bio Private Limited (BugSpeaks)
Leucine Rich Bio Private Limited is the primary company behind BugSpeaks. The board of Leucine Rich Bio Private Limited currently have 4 directors; the longest-serving is Prabhath Manjappa Kamath, appointed in 2014. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prabhath Manjappa Kamath DIN 06836130 | Director | 21 Aug 2014 | 12 yrs 2 mo | Leucine Rich Bio Private Limited |
| Kumar Sankaran DIN 06895658 | Director | 21 Aug 2014 | 12 yrs 2 mo | Leucine Rich Bio Private Limited |
| Debojyoti Dhar DIN 07286366 | Director | 30 Sep 2015 | 11 yrs 1 mo | Leucine Rich Bio Private Limited |
| Naveen Chava DIN 03517306 | Director | 01 Aug 2024 | 2 yrs 3 mo | Leucine Rich Bio Private Limited |
People of BugSpeaks
3 people are tracked at BugSpeaks (3 in leadership); the tracked headcount is 17.
| Name | Role | Group |
|---|---|---|
| Co-Founder, CEO | Leadership | |
| Co-Founder, CPO | Leadership | |
| Co-Founder, Director | Leadership |
Complete people profiles for BugSpeaks
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of BugSpeaks
Figures of Leucine Rich Bio Private Limited, the primary company behind BugSpeaks, for FY 2024. Revenue was ₹1.62 Cr (+57% year on year). Net loss was -₹54 Lakh (-33% margin). EBITDA was -₹34.6 Lakh (-21% margin). Revenue has grown at a compounded annual rate of +51% over three years and +25% over five years.
- ₹1.62 CrRevenue · FY 2024 · +57% YoY
- -₹54 LakhNet loss · -33% margin
- -₹34.6 LakhEBITDA · -21% margin
- ₹1.4 LakhPaid-up capital
- 17Employees (provident fund records)
- +51%Revenue CAGR, 3 years
- +25%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Leucine Rich Bio Private Limited are on its company page.
Detailed financial statements for BugSpeaks
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of BugSpeaks
The website of BugSpeaks (bugspeaks.com) receives about 30.4K visits a month.
- Monthly visits30.4K
▲ 20.7% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bugspeaks
Complete news archive for BugSpeaks
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BugSpeaks
BugSpeaks was founded in 2014.
BugSpeaks is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Kumar Sankaran is the CEO of BugSpeaks, as recorded in our data. They have also founded this company.
BugSpeaks has 17 employees.
The primary company behind BugSpeaks, Leucine Rich Bio Private Limited, reported revenue of ₹1.62 Cr for FY 2024, up 57% year on year.
Leucine Rich Bio , Based In Bangalore, India, Focuses On Gut Microbiome Testing Through The Bugspeaks Platform. They Collect And Analyze Stool Samples To Deliver Reports With Tailored Recommendations For Prebiotics, Probiotics, And Food To Enhance Immunity, Digestion, And Manage Conditions Like Diabetes. The Company Serves Individuals And Partners With Clinics, Emphasizing Transparency And Accuracy In Health Insights.
BugSpeaks offers BugSpeaks Test and Probiotics and Synbiotics.
BugSpeaks operates through Leucine Rich Bio Private Limited.
The legal entities of BugSpeaks currently have 4 directors, including Naveen Chava, Prabhath Manjappa Kamath, Debojyoti Dhar and others.